BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Science/Technology SCI

Engineering Biology ---H.R.4373: Engineering Biology Research and Development Act ---Bioeconomy Research and Development Act Discussion Draft

Contacted: Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; U.S. Trade Representative (USTR); Treasury, Dept of; Council of Economic Advisers (CEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); SENATE; Securities & Exchange Commission (SEC); Natl Economic Council (NEC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Small Business Administration (SBA); Agriculture, Dept of (USDA)

Bills named: H.R. 4373 (116th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.3006: Support RFS Integrity Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.4385: Small Refinery Exemption Fairness Act of 2019 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Incentives for Sustainable Aviation Fuels ---RFI from House Select Committee on the Climate Crisis ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit Funding for Biofuels ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Incentives for Sustainable Aviation Fuels ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Transportation, and Housing and Urban Development, and Related Agencies Act for FY 2021 Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Biorefineries ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Renewable Fuel Standard (RFS) ---H.R.3006: Support RFS Integrity Act of 2019 ---H.R.4385: Small Refinery Exemption Fairness Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Cellulosic Registration Applications for Corn Kernel Fiber ---RFI from House Select Committee on the Climate Crisis ---RFS Reform ---Small Refinery Waivers

Contacted: Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Council of Economic Advisers (CEA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Office of the Vice President of the United States; Natl Economic Council (NEC); White House Office; Treasury, Dept of; Office of Management & Budget (OMB)

Bills named: S. 1841 (116th), H.R. 6379 (116th), H.R. 3249 (116th), H.R. 3006 (116th), S. 1840 (116th), H.R. 748 (116th), H.R. 4385 (116th), S. 3548 (116th)

Health Issues HCR

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee 340B Drug Discount Program ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---National Biodefense Strategy Biosimilars ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 ---Implementation and Reauthorization of the Biosimilar User Fee Act of 2017 Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Drug Supply Chain Management ---Home Administration of Part B Drugs ---Medicare Reimbursement Policies ---Patient Cost-Sharing and Smoothing ---R&D Funding for Medical Countermeasures ---Reasonable Pricing Provisions Diagnostics and Personalized Medicine Regulation and Oversight ---H.R.6102/S3404: VALID Act of 2020 Drug Evaluation and Review ---S.1617: Second Look at Drug Patents Act of 2019 ---Patient-Focused Drug Development ---Regulatory Reform & Modernization ---Use of Real-World Evidence Drug Importation ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---General Drug Manufacturing, Quality & Distribution ---Drug Shortages ---Supply Chain Integrity and Traceability Drug Patenting ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous prices (FLAT) prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 Drug Pricing ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous Prices (FLAT) Prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.2376/S.1227: Prescription Pricing for the People Act of 2019 ---H.R.2387: STOP GAMES Act of 2019 ---H.R.3199 Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---CMMI Authority ---General ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 ---Reasonable Pricing Provisions Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for FDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Health Resources and Services Administration (HRSA) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for National Institutes of Health ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Medicaid ---H.R.5741: Strengthening Innovation in Medicare and Medicaid Act of 2020 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Alternative payment arrangements for gene therapies ---Pricing and Rebates Opioid Crisis ---General ---Implementation of the SUPPORT for Patients and Communities Act of 2018 Orphan Drug Issues ---H.R.4712: Fairness in Orphan Drug Exclusivity Act of 2019 ---Tax Credit Rare Pediatric Disease Priority Review ---H.R.4439: Creating Hope Reathorization Act of 2019 Reimbursement and Coverage of Innovative Products ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---S.2326: New Opportunities for Value that Extend Lives (NOVEL) Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Administration Rebate Rule ---CMMI Authority ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Home Administration of Part B Drugs ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Patient Cost-Sharing and Smoothing ---Step Therapy ---Support of Patient Premiums and Cost-Sharing Obligations ---Surprise Billing ---Value-based Contracting and Communications The United States-Mexico-Canada Agreement ---IP Provisions US-China Trade Negotiations ---IP Provisions US-Japan Trade Agreement ---IP Provisions US-Kenya Trade Agreement ---IP Provisions US-UK Trade Agreement ---IP Provisions Vaccine Injury Compensation Program Tax ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 202 ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 Vaccines and Infectious Diseases ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.5076/S.1872: Protecting Seniors through Immunizations Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 ---Vaccine and Anti-Microbial Resistance Product Development and Incentives

Contacted: Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Small Business Administration (SBA); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); SENATE; Food & Drug Administration (FDA); Council of Economic Advisers (CEA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; White House Office; Office of the Vice President of the United States; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Natl Institutes of Health (NIH)

Bills named: S. 3548 (116th), S. 2543 (116th), H.R. 2387 (116th), H.R. 1520 (116th), S. 1617 (116th), S. 1872 (116th), H.R. 5741 (116th), H.R. 5076 (116th), H.R. 3199 (116th), H.R. 6201 (116th), H.R. 4712 (116th), S. 2326 (116th), H.R. 4398 (116th), S. 1227 (116th), H.R. 3 (116th), H.R. 5133 (116th), H.R. 3991 (116th), S. 659 (116th), H.R. 748 (116th), H.R. 1046 (116th), S. 3129 (116th), H.R. 4100 (116th), H.R. 6102 (116th), H.R. 6074 (116th), H.R. 1188 (116th), H.R. 4439 (116th), S. 1416 (116th), H.R. 19 (116th), S. 1654 (116th), H.R. 1499 (116th), S. 1895 (116th), S. 1712 (116th), S. 377 (116th), H.R. 2376 (116th), S. 64 (116th), H.R. 1973 (116th), H.R. 1503 (116th), S. 366 (116th)

Taxation/Internal Revenue Code TAX

Biofuels (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Incentives for Sustainable Aviation Fuels ---Sustainable Aviation Fuels Tax Credit Capital Formation Investment Incentives ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Introduction of the American Innovation Act in the Senate ---Reform of Net Operating Loss Rules ---Reintroduction of the American Innovation Act in the House Orphan Drug Issues ---Tax Credit Qualified Small Business Stock (QSBS) Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---Investment Tax Credit ---Production Tax Credit Research & Development Tax Credit Reforms ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Expensing of R&D Expenditures ---Incentives for Sustainable Aviation Fuels ---R&D Payroll Credit Vaccine Injury Compensation Tax ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.1973/S.1654: Vaccine Access Improvement Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); White House Office; SENATE; Natl Economic Council (NEC); Office of the Vice President of the United States; Small Business Administration (SBA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Council of Economic Advisers (CEA); U.S. Trade Representative (USTR)

Bills named: H.R. 3249 (116th), H.R. 6074 (116th), H.R. 748 (116th), S. 1841 (116th), H.R. 6201 (116th), H.R. 6379 (116th), H.R. 1973 (116th), S. 1654 (116th), S. 3548 (116th)

Trade (domestic/foreign) TRD

Committee on Foreign Investment in the United States (CFIUS) ---Implementation of Foreign Investment Risk Review Modernization Act (FIRRMA) of 2017 Drug Importation ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---General Drug Pricing ---International Pricing Index Proposal Foreign Agricultural Biotechnology Laws and Regulations ---EU Ag-Biotech Policies and Regulations ---Korea Biotechnology Regulations Intellectual Property International Enforcement ---China ---India The United States-Mexico-Canada Agreement ---Ag-Biotech Provisions ---IP Provisions US-China Trade Negotiations ---Ag Biotech Provisions ---IP Provisions US-Japan Trade Agreement ---Ag-Biotech Provisions ---IP Provisions US-Kenya Trade Agreement ---IP Provisions US-UK Trade Agreement ---Ag-Biotech Provisions ---IP Provisions World Trade Organization - Special 301 Submissions ---China ---India

Contacted: Centers For Medicare and Medicaid Services (CMS); Council of Economic Advisers (CEA); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Treasury, Dept of; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB); Patent & Trademark Office (PTO); SENATE; Office of the Vice President of the United States; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); U.S. Trade Representative (USTR)

Bills named: S. 377 (116th), H.R. 1046 (116th)

Agriculture AGR

Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Priority Zoonotic Animal Drugs Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Korea Biotechnology Regulations Funding for Biomass Crop Assistance Program ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for the USDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Farm Bill Programs Energy Title IX ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology Genetically Engineered (GE) Plants ---EPA Regulatory Approach to Gene Editing The United States-Mexico-Canada Agreement ---Ag-Biotech Provisions US-China Trade Negotiations ---Ag Biotech Provisions US-Japan Trade Agreement ---Ag-Biotech Provisions US-UK Trade Agreement ---Ag-Biotech Provisions USDA/APHIS Agricultural Biotechnology Regulations ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Regulatory Treatment of Gene Edited Products

Contacted: Office of the Vice President of the United States; White House Office; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Council of Economic Advisers (CEA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Treasury, Dept of; Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Small Business Administration (SBA)

Bills named: H.R. 748 (116th), S. 3548 (116th)

Copyright/Patent/Trademark CPT

Bayh-Dole Act/Tech Transfer ---Bayh-Dole 40th Anniversary ---March-In Rights Compulsory Licensing ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 Drug Patenting ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous prices (FLAT) prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.659: Biologic Patent Transparency Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 Intellectual Property International Enforcement ---China ---India Inter Partes Review ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.3666/S.2082: Support Technology and Research for Our Nation's Growth and Economic Resilience (STRONGER) Patents Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.440 PACED Act of 2019 ---Implementation of the America Invents Act of 2011 Patent Reform ---H.R.3199: Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---Patent Litigation Reforms Patenting of Biological Inventions ---Section 101 Modernization The United States-Mexico-Canada Agreement ---IP Provisions US-China Trade Negotiations ---IP Provisions US-Japan Trade Agreement ---IP Provisions US-Kenya Trade Agreement ---IP Provisions US-UK Trade Agreement ---IP Provisions

Contacted: Council of Economic Advisers (CEA); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Natl Economic Council (NEC); Agriculture, Dept of (USDA); White House Office; SENATE; Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Office of the Vice President of the United States

Bills named: S. 377 (116th), H.R. 5133 (116th), H.R. 1188 (116th), S. 366 (116th), H.R. 19 (116th), S. 2082 (116th), S. 440 (116th), H.R. 1520 (116th), H.R. 4398 (116th), H.R. 3991 (116th), H.R. 3666 (116th), S. 64 (116th), S. 1895 (116th), H.R. 1503 (116th), S. 1416 (116th), H.R. 3199 (116th), H.R. 1046 (116th), S. 1617 (116th), S. 3129 (116th), H.R. 1499 (116th), S. 659 (116th)

Small Business SMB

Capital Market Enhancements ---Accredited Investor Definition ---Amended Definition of Smaller Reporting Company Coronavirus (COVID-19) Small Business Loans (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Affiliation ---Eligibility Funding for Coronavirus (COVID-19) Small Business Loans ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 Proxy Advisory Services ---H.R.4015: Corporate Governance Reform and Transparency Act of 2017 ---S.3614: Corporate Governance Fairness Act of 2018 ---Impact of Policies on Small Public Companies Sarbanes Oxley Section 404 (b) ---H.R.3886/S.452: Fostering Innovation Act of 2019 ---Small Issuer Exemption Short Selling Transparency Small Business Innovation Research (SBIR) Program

Contacted: Council of Economic Advisers (CEA); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Treasury, Dept of; U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Food & Drug Administration (FDA); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 748 (116th), H.R. 4015 (116th), S. 3548 (116th), S. 452 (116th), H.R. 3886 (116th), S. 3614 (116th)

Medicare/Medicaid MMM

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Home Administration of Part B Drugs ---Medicare Reimbursement Policies ---Patient Cost-Sharing and Smoothing ---Reasonable Pricing Provisions Drug Pricing ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---H.R.1188/S.366: Forcing Limits on Abusive and Tumultuous (FLAT) Prices Act of 2019 ---H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019 ---H.R.1503: Orange Book Transparency Act of 2019 ---H.R.1520: Purple Book Continuity Act of 2019 ---H.R.2376/S.1227: Prescription Pricing for the People Act of 2019 ---H.R.2387: STOP GAMES Act of 2019 ---H.R.3199 Terminating the Extension of Rights Misappropriated (TERM) Act of 2019 ---H.R.3991 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---S.64: Preserve Access to Affordable Generics and Biosimilars Act of 2019 ---S.1416/H.R.4398/H.R.3991/H.R.5133: Affordable Prescriptions for Patients Act of 2019 ---S.1617: Second Look at Drug Patents Act of 2019 ---S.1895: Lower Health Care Costs for Patients Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---CMMI Authority ---General ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---International Pricing Index Proposal ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 ---Reasonable Pricing Provisions Medicaid ---H.R.5741: Strengthening Innovation in Medicare and Medicaid Act of 2020 ---Alternative payment arrangements for gene therapies ---Pricing and Rebates Reimbursement and Coverage of Innovative Products ---H.R.3: Lower Drug Costs Now Act of 2019 ---H.R.19/S.3129: Lower Costs, More Cures Act of 2019 ---S.2326: New Opportunities for Value that Extend Lives (NOVEL) Act of 2019 ---S.2543: Prescription Drug Pricing Reduction Act of 2019 ---Administration Rebate Rule ---CMMI Authority ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Home Administration of Part B Drugs ---International Pricing Index Proposal ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Patient Cost-Sharing and Smoothing ---Step Therapy ---Support of Patient Premiums and Cost-Sharing Obligations ---Surprise Billing ---Value-based Contracting and Communications Vaccines and Infectious Diseases ---H.R.5076/S.1872: Protecting Seniors through Immunizations Act of 2019

Contacted: Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); White House Office; Council of Economic Advisers (CEA); SENATE; Office of the Vice President of the United States; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Treasury, Dept of; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC)

Bills named: H.R. 4398 (116th), H.R. 1188 (116th), S. 2543 (116th), S. 1227 (116th), H.R. 1499 (116th), H.R. 2387 (116th), H.R. 748 (116th), H.R. 3199 (116th), S. 3129 (116th), S. 1617 (116th), H.R. 6074 (116th), H.R. 5076 (116th), S. 1895 (116th), H.R. 1503 (116th), H.R. 5133 (116th), S. 64 (116th), H.R. 6201 (116th), S. 2326 (116th), H.R. 5741 (116th), H.R. 3991 (116th), S. 3548 (116th), S. 377 (116th), H.R. 3 (116th), H.R. 2376 (116th), S. 1872 (116th), H.R. 19 (116th), H.R. 1520 (116th), H.R. 1046 (116th), S. 1416 (116th), S. 366 (116th)

Budget/Appropriations BUD

Coronavirus (COVID-19) Pandemic ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biofuels ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Incentives for Sustainable Aviation Fuels ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Transportation, and Housing and Urban Development, and Related Agencies Act for FY 2021 Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Biorefineries ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Funding for Coronavirus (COVID-19) Small Business Loans ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 Funding for FDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Health Resources and Services Administration (HRSA) - Vaccine Injury Compensation Program (VICP) ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for National Institutes of Health ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Renewable Chemicals/Bio-based Products ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the HHS Office of Infectious Disease and HIV/AIDS Policy ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the USDA ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Farm Bill Programs Energy Title IX ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC)

Contacted: Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Council of Economic Advisers (CEA); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); White House Office; Small Business Administration (SBA); Patent & Trademark Office (PTO); Treasury, Dept of; Office of Management & Budget (OMB)

Bills named: H.R. 6201 (116th), S. 1712 (116th), S. 3548 (116th), H.R. 748 (116th), H.R. 4100 (116th), H.R. 6074 (116th), H.R. 6379 (116th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.2051/S.999: Sustainable Chemistry Research and Development Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---Bioeconomy Research and Development Act of 2020 (Discussion Draft House) ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Investment Tax Credit ---Production Tax Credit

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Treasury, Dept of; SENATE; Natl Economic Council (NEC); White House Office; Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Council of Economic Advisers (CEA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Office of the Vice President of the United States

Bills named: H.R. 2051 (116th), S. 1841 (116th), S. 999 (116th), H.R. 3249 (116th), H.R. 748 (116th), S. 3548 (116th)

Consumer Issues/Safety/Products CSP

Drug Importation ---H.R.1046/S.377: Medicare Negotiation and Competitive Licensing Act of 2019 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---General Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology Opioid Crisis ---General ---Implementation of the SUPPORT for Patients and Communities Act of 2018

Contacted: Office of the Vice President of the United States; Council of Economic Advisers (CEA); Patent & Trademark Office (PTO); SENATE; Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Natl Economic Council (NEC); Treasury, Dept of; Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 3548 (116th), H.R. 748 (116th), S. 377 (116th), H.R. 1046 (116th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.3006: Support RFS Integrity Act of 2019 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.4385: Small Refinery Exemption Fairness Act of 2019 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Incentives for Sustainable Aviation Fuels ---RFI from House Select Committee on the Climate Crisis ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit Funding for Biofuels ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6379: Take Responsibility for Workers and Families Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Incentives for Sustainable Aviation Fuels ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) ---Transportation, and Housing and Urban Development, and Related Agencies Act for FY 2021 Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 Funding for Biorefineries ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Energy and Water Development and Related Agencies Appropriations Act for FY 2021 ---Increased Borrowing Authority for the Commodity Credit Corporation (CCC) Renewable Fuel Standard (RFS) ---H.R.3006: Support RFS Integrity Act of 2019 ---H.R.4385: Small Refinery Exemption Fairness Act of 2019 ---S.1840: A bill to establish certain requirements for the small refineries exemption of the renewable fuels provisions under the Clean Air Act, and for other purposes. ---Climate Leadership and Environmental Action for our Nations (CLEAN) Future Act (Discussion Draft House) ---Cellulosic Registration Applications for Corn Kernel Fiber ---RFI from House Select Committee on the Climate Crisis ---RFS Reform ---Small Refinery Waivers

Contacted: Patent & Trademark Office (PTO); Council of Economic Advisers (CEA); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB); Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Natl Economic Council (NEC); Small Business Administration (SBA); U.S. Trade Representative (USTR); Treasury, Dept of; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4385 (116th), S. 1840 (116th), S. 3548 (116th), H.R. 6379 (116th), H.R. 748 (116th), H.R. 3249 (116th), H.R. 3006 (116th), S. 1841 (116th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Natl Economic Council (NEC); Office of the Vice President of the United States; Treasury, Dept of; Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Council of Economic Advisers (CEA); White House Office; U.S. Trade Representative (USTR)

Bills named: S. 3548 (116th), H.R. 748 (116th)

Animals ANI

Genetically Engineered (GE) Animals ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ------Amendment on GE Salmon Labeling ---FDA Regulatory Approach to Animal Biotechnology ---Priority Zoonotic Animal Drugs ---USDA Authority to Review Animal Biotechnology

Contacted: U.S. Trade Representative (USTR); Office of the Vice President of the United States; Securities & Exchange Commission (SEC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Council of Economic Advisers (CEA); Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); Treasury, Dept of; Patent & Trademark Office (PTO); White House Office; Health & Human Services, Dept of (HHS); SENATE; Natl Economic Council (NEC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), S. 3548 (116th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---National Biodefense Strategy Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021

Contacted: SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; White House Office; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Office of the Vice President of the United States; Securities & Exchange Commission (SEC); Small Business Administration (SBA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Council of Economic Advisers (CEA)

Bills named: H.R. 6074 (116th), S. 3548 (116th), H.R. 748 (116th), S. 1712 (116th), H.R. 6201 (116th), H.R. 4100 (116th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-funding) ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---H.R.6201: Families First Coronavirus Response Act of 2020 ---Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 ---National Biodefense Strategy Funding for Antimicrobial Resistance Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.4100/S.1712: DISARM Act of 2019 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2021 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021 Funding for National Institutes of Health ---H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---H.R.6074: Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Labor, Health and Human Services, Education, and Related Agencies Appropriations Act for FY 2021

Contacted: SENATE; Securities & Exchange Commission (SEC); Council of Economic Advisers (CEA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Small Business Administration (SBA); Agriculture, Dept of (USDA); Office of the Vice President of the United States; Patent & Trademark Office (PTO); Treasury, Dept of; Natl Institutes of Health (NIH); Natl Economic Council (NEC); Office of Management & Budget (OMB); White House Office; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 6074 (116th), H.R. 6201 (116th), S. 1712 (116th), S. 3548 (116th), H.R. 748 (116th), H.R. 4100 (116th)